Biological E. Limited shared that Kamal Kumar Upadhyay Ph.D has been invited to serve as a Moderator at the workshop “Navigating the GLP-1 Generic Drug Pathway,” organized by the Center for Research on Complex Generics (CRCG) on September 23–24, 2026, at The Universities at Shady Grove, Maryland.

Biological E. Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognised vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health and survival of people and contribute to the societies BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programs in India for over five decades. Our portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and our future offerings promise to be even more exciting.